Overview

InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral Antipsychotics

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
International Observational Registry on Schizophrenia
Details
Lead Sponsor:
Janssen-Cilag International NV
Treatments:
Antipsychotic Agents
Risperidone